Stock 4978 REPROCELL INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

All News ReproCELL Incorporated

Equities

4978

JP3974770004

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
133 JPY -2.21% Intraday chart for ReproCELL Incorporated -6.99% -24.00%
2023 ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd. CI
2023 ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.
CI
ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding
CI
ReproCELL Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Clinical Trials: An Evolutionary Perspective
PU
Histocell, S.L. announced that it expects to receive ?0.4 million in funding from ReproCELL Incorporated
CI
ReproCELL Incorporated : 4 ways ex vivo models offer Pharma better alternatives to animal testing
PU
ReproCELL Incorporated : How human fresh tissue models are helping RCD405 achieve regulatory approval
PU
ReproCELL Incorporated : Everything we know about the 5HT1B receptor
PU
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study
CI
ReproCELL Incorporated : Skin biopsy and ex vivo culture methods
PU
ReproCELL Incorporated : The influence of the microbiome on inflammatory bowel diease
PU
ReproCELL Incorporated : What is Human Tissue Testing?
PU
ReproCELL Incorporated : co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development
PU
ReproCELL Incorporated : Solutions for Skin Disease Researchers
PU
ReproCELL Incorporated : Predicting Psoriasis Drug Efficacy in Human Skin
PU
ReproCELL Incorporated : How SynFire® Technology can benefit your research
PU
ReproCELL Incorporated : Inserts or plates for your 3D cell culture?
PU
ReproCELL Incorporated : How to improve your 3D Cell Culture using Small-scale Perfusion Systems
PU
ReproCELL Incorporated : Biotechgate Digital Partnering 2022 7 - 11 February 2022 • Virtual Meeting
PU
ReproCELL Incorporated : Enhance your epithelial barriers assay using Alvetex
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4978 Stock
  4. News ReproCELL Incorporated
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW